Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

DOI: https://doi.org/10.1182/blood-2016-06-725010

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-04-639203.].

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Chao Hu,Mengxia Yu,Yanling Ren,Kongfei Li,Dominic M. Maggio,Chen Mei,Li Ye,Juying Wei,Jie Jin,Zhengping Zhuang,Hongyan Tong

DOI: https://doi.org/10.1038/s41598-017-14858-z

IF: 4.6

2017-01-01

Scientific Reports

Abstract:correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347

DOI: https://doi.org/10.1182/bloodadvances.2017015438

2018-01-09

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2017012732.].
Erratum: Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Adv. 2017;1(14):933-946

DOI: https://doi.org/10.1182/bloodadvances.2017011148

2017-08-17

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2016004176.].
Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Hongfeng Huang,Qixia Shen,Jingyi Zhou,Xiuyan Yang,Qiuqin Cai,Jia Shen,Shi Feng,Wenqing Xie,Hong Jiang,Jianghua Chen

DOI: https://doi.org/10.3389/fimmu.2022.1052676

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.995243.].
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum

Zhongqing Zou,Tingting Guo,Jian Cui,Wenjiao Tang,Yan Li,Fangfang Wang,Tian Dong,Yunfan Yang,Yan Feng,Matthew Ho,Li Zhang,Ling Pan,Ting Niu

DOI: https://doi.org/10.7150/jca.79561

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.53209.].

oncology
Erratum: Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126

DOI: https://doi.org/10.1182/blood-2016-07-730580

IF: 20.3

2016-09-08

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2016-02-699082.].
Erratum: Veenstra RG, Flynn R, Kreymborg K, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 2015;125(21):3335-3346

DOI: https://doi.org/10.1182/blood-2016-04-711242

IF: 20.3

2016-06-16

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2014-09-603357.].
Erratum: Schwartz CL, Constine LS, Villaluna D, et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009;114(10):2051-2059

DOI: https://doi.org/10.1182/blood-2016-06-723056

IF: 20.3

2016-07-28

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2008-10-184143.].
Erratum: Aldenhoven M, van den Broek BTA, Wynn RF, et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. Blood Adv. 2017;1(24):2236-2242

DOI: https://doi.org/10.1182/bloodadvances.2017014407

2017-12-07

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2017011387.].
Correction To: Basiliximab Versus Rabbit Antithymocyte Globulin As Induction Therapy for Living-Related Renal Transplantation: a Single-Center Experience

Hongfeng Huang,Jingyi Zhou,Wenqing Xie,Jiang Wu,Hao Deng,Jianghua Chen

DOI: https://doi.org/10.1007/s11255-019-02082-9

IF: 2.2662

2019-01-01

International Urology and Nephrology

Abstract:In the original publication, incorrect grant number was included in the Acknowledgements text as 'This study (article) was supported by Natural Science Foundation Y16H050011 of Zhejiang Province, China'. The correct acknowledgement section is given here.
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Erratum: Palumbo A, Bringhen S, Mateos M-V, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068-2074

DOI: https://doi.org/10.1182/blood-2016-07-727081

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2014-12-615187.].
Erratum: Approaching hemophagocytic lymphohistiocytosis

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1369687

IF: 7.3

2024-01-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1210041.].

immunology
Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

DOI: https://doi.org/10.1097/HS9.0000000000000987

2023-10-31

HemaSphere

Abstract:[This corrects the article DOI: 10.1097/HS9.0000000000000907.].
Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Mei Kong,Zhaoming Wang,Xiaodong Teng,Liming Xu,Jimin Liu,Chenyang Jiang,Lisong Teng

2019-01-01

Abstract:[This corrects the article on p. 1674 in vol. 11, PMID: 31938268.].
Erratum: Development of Auer bodies from giant inclusions associated with rough endoplasmic reticulum in acute promyelocytic leukemia

DOI: https://doi.org/10.1097/BS9.0000000000000163

2023-05-30

Abstract:[This corrects the article DOI: 10.1097/BS9.0000000000000145.].
Erratum: Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650

DOI: https://doi.org/10.1182/blood-2016-03-703744

IF: 20.3

2016-04-14

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-03-635532.].
Corrigendum to “Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma” [Genes Dis 6(4) 2019 407–418]

Junling Tang,Li Zhang,Tiejun Zhou,Zhiwei Sun,Liangsheng Kong,Li Jing,Hongyun Xing,Hongyan Wu,Yongli Liu,Shixia Zhou,Jingyuan Li,Mei Chen,Fang Xu,Jirui Tang,Tao Ma,Min Hu,Dan Liu,Jing Guo,Xiaofeng Zhu,Yan Chen,Ting Ye,Jianyu Wang,Xiaoming Li,H. Rosie Xing

DOI: https://doi.org/10.1016/j.gendis.2021.06.001

2022-01-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2018.12.002.].

genetics & heredity,biochemistry & molecular biology
Erratum: Reichenbach DK, Schwarze V, Matta BM, et al. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. Blood. 2015;125(20):3183-3192

DOI: https://doi.org/10.1182/blood-2016-07-728048

IF: 20.3

2016-09-01

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2014-10-606830.].

Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347

Erratum: Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Adv. 2017;1(14):933-946

Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum

Erratum: Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126

Erratum: Veenstra RG, Flynn R, Kreymborg K, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 2015;125(21):3335-3346

Erratum: Schwartz CL, Constine LS, Villaluna D, et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009;114(10):2051-2059

Erratum: Aldenhoven M, van den Broek BTA, Wynn RF, et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. Blood Adv. 2017;1(24):2236-2242

Correction To: Basiliximab Versus Rabbit Antithymocyte Globulin As Induction Therapy for Living-Related Renal Transplantation: a Single-Center Experience

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Erratum: Palumbo A, Bringhen S, Mateos M-V, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068-2074

Erratum: Approaching hemophagocytic lymphohistiocytosis

Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Erratum: Development of Auer bodies from giant inclusions associated with rough endoplasmic reticulum in acute promyelocytic leukemia

Erratum: Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650

Corrigendum to “Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma” [Genes Dis 6(4) 2019 407–418]

Erratum: Reichenbach DK, Schwarze V, Matta BM, et al. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. Blood. 2015;125(20):3183-3192